ERIN HANAUER: Open Payments
NPI 1851490718 · PETALUMA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 10 payments from 8 companies in 2025. Trend: 2023 $230 · 2024 $154 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Organon LLC | 1 | $33 |
| Arcutis Biotherapeutics, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| Incyte Corporation | 1 | $26 |
| MIMEDX Group, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
Products named: LIBTAYO, Rhapsido, Zoryve, TALTZ, OPZELURA, SKYRIZI.
Industry payments across CA — which companies pay providers there.
